Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01990300 ↗	Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus	Completed	Takeda		2011-11-28	The purpose of this survey is to examine the safety and efficacy of long-term use of alogliptin/pioglitazone(Liovel) combination tablets in patients with type 2 diabetes mellitus determined as warranting combination therapy with alogliptin benzoate and pioglitazone hydrochloride
NCT03499704 ↗	A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy	Recruiting	Celltrion Pharm, Inc.	Phase 4	2020-02-11	The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52.
NCT03499704 ↗	A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy	Recruiting	Takeda	Phase 4	2020-02-11	The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c) change from baseline at Week 52.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Intervention	Trials
Type 2 Diabetes Mellitus	2
Diabetes Mellitus, Type 2	1
Non-alcoholic Steatohepatitis	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Intervention	Trials
Diabetes Mellitus, Type 2	4
Diabetes Mellitus	3
Non-alcoholic Fatty Liver Disease	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Location	Trials
Korea, Republic of	3
Japan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Clinical Trial Phase	Trials
Recruiting	2
Active, not recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Sponsor	Trials
Takeda	2
Celltrion Pharm, Inc.	1
Yonsei University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Sponsor	Trials
Industry	3
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.